BAJAJ BROKING

Notification
No new Notification messages
Stallion India Fluorochemicals IPO is Open!
Apply for the Stallion India Fluorochemicals IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
gujarat terce laboratories ltd stock

GUJARAT TERCE LABORATORIES LTD Share Price

70.49 -0.50 (-0.70%)
Jan 15 2025 03:10 PM Pharmaceuticals NSE: GUJTERC

GUJARAT TERCE LABORATORIES LTD Share Price Update

As of the latest trading session, GUJARAT TERCE LABORATORIES LTD share price is currently at 70.49, which is down by -0.50 from its previous closing. Today, the stock has fluctuated between 68.11 and 74.49. Over the past year, GUJARAT TERCE LABORATORIES LTD has achieved a return of 114.14 %. In the last month alone, the return has been -15.00 %. Read More...

GUJARAT TERCE LABORATORIES LTD Performance

Day Range

Low68.11 High74.49
70.49

52 Week Range

Low 27.02 High 94.90
70.49

GUJARAT TERCE LABORATORIES LTD Share Price

524314

GUJTERC

img img img img
No Data Available

Open Price

74.49

Prev. Close

70.99

Volume (Shares)

1869.00

Total traded value

1.31

Upper Circuit

74.01

Lower Circuit

66.97

Note: The current prices & values are delayed, Login to your account for live updates.

GUJARAT TERCE LABORATORIES LTD Fundamentals


(Standalone)

Market Cap (Cr) 52.30
PE Ratio (TTM) 19.97
Book Value / Share 11.94
Beta 0.00
ROE 2.96%
EPS (TTM) 3.53
Dividend Yield 0.00%
Net Profit Qtr (Cr) 1.48

GUJARAT TERCE LABORATORIES LTD Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars SEP 2024 (Values in Cr)
Revenue 13.30
Operating Expense 11.86
Net Profit 1.48
Net Profit Margin (%) 11.12
Earnings Per Share (EPS) 2.00
EBITDA 1.73
Effective Tax Rate (%) 1.98
Particulars JUN 2024 (Values in Cr)
Revenue 11.89
Operating Expense 12.03
Net Profit -0.08
Net Profit Margin (%) -0.67
Earnings Per Share (EPS) -0.10
EBITDA 0.15
Effective Tax Rate (%) -14.28
Particulars MAR 2024 (Values in Cr)
Revenue 12.21
Operating Expense 11.45
Net Profit 0.54
Net Profit Margin (%) 4.42
Earnings Per Share (EPS) 0.73
EBITDA 1.08
Effective Tax Rate (%) 35.71
Particulars DEC 2023 (Values in Cr)
Revenue 13.02
Operating Expense 12.42
Net Profit 0.67
Net Profit Margin (%) 5.14
Earnings Per Share (EPS) 0.91
EBITDA 0.92
Effective Tax Rate (%) 0.00
Particulars SEP 2023 (Values in Cr)
Revenue 12.03
Operating Expense 11.78
Net Profit 0.33
Net Profit Margin (%) 2.74
Earnings Per Share (EPS) 0.45
EBITDA 0.62
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Revenue 47.97
Operating Expense 47.76
Net Profit 0.24
Net Profit Margin (%) 0.50
Earnings Per Share (EPS) 0.33
EBITDA 1.59
Effective Tax Rate (%) 55.55
Particulars MAR 2023 (Values in Cr)
Revenue 46.78
Operating Expense 50.03
Net Profit -1.67
Net Profit Margin (%) -3.56
Earnings Per Share (EPS) -2.25
EBITDA -1.81
Effective Tax Rate (%) 42.21
Particulars MAR 2022 (Values in Cr)
Revenue 40.13
Operating Expense 39.69
Net Profit 0.87
Net Profit Margin (%) 2.16
Earnings Per Share (EPS) 1.18
EBITDA 1.43
Effective Tax Rate (%) -17.33
Particulars MAR 2021 (Values in Cr)
Revenue 25.18
Operating Expense 28.51
Net Profit -2.52
Net Profit Margin (%) -10.00
Earnings Per Share (EPS) -3.40
EBITDA -1.95
Effective Tax Rate (%) 0.39
Particulars MAR 2020 (Values in Cr)
Revenue 37.54
Operating Expense 37.39
Net Profit 0.28
Net Profit Margin (%) 0.74
Earnings Per Share (EPS) 0.37
EBITDA 0.97
Effective Tax Rate (%) 36.36
Particulars MAR 2024 (Values in Cr)
Book Value / Share 9.58
ROE % 2.96
ROCE % 7.17
Total Debt to Total Equity 0.80
EBITDA Margin 3.31
Particulars MAR 2023 (Values in Cr)
Book Value / Share 9.25
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.91
EBITDA Margin -3.87
Particulars MAR 2022 (Values in Cr)
Book Value / Share 11.50
ROE % 10.24
ROCE % 6.74
Total Debt to Total Equity 0.70
EBITDA Margin 3.54
Particulars MAR 2021 (Values in Cr)
Book Value / Share 10.33
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.39
EBITDA Margin -7.82
Particulars MAR 2020 (Values in Cr)
Book Value / Share 14.97
ROE % 2.55
ROCE % 5.04
Total Debt to Total Equity 0.15
EBITDA Margin 2.58
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.09
Total Assets 23.27
Total Liabilities 23.27
Total Equity 7.10
Share Outstanding 7420300
Price to Book Ratio 5.53
Return on Assets (%) 1.04
Return on Capital (%) 2.22
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 2.02
Total Assets 28.52
Total Liabilities 28.52
Total Equity 6.86
Share Outstanding 7420300
Price to Book Ratio 1.80
Return on Assets (%) -5.85
Return on Capital (%) -11.83
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 1.50
Total Assets 27.39
Total Liabilities 27.39
Total Equity 8.53
Share Outstanding 7420300
Price to Book Ratio 2.27
Return on Assets (%) 3.18
Return on Capital (%) 5.74
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 1.28
Total Assets 21.87
Total Liabilities 21.87
Total Equity 7.66
Share Outstanding 7420300
Price to Book Ratio 0.67
Return on Assets (%) -11.52
Return on Capital (%) -20.33
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.04
Total Assets 22.50
Total Liabilities 22.50
Total Equity 11.11
Share Outstanding 7420300
Price to Book Ratio 0.42
Return on Assets (%) 1.22
Return on Capital (%) 2.02
Particulars MAR 2024 (Values in Cr)
Net Income 0.54
Cash from Operations 2.59
Cash from Investing -0.45
Cash from Financing -4.08
Net change in Cash -1.93
Free Cash Flow 2.67
Particulars MAR 2023 (Values in Cr)
Net Income -2.89
Cash from Operations 0.06
Cash from Investing 0.61
Cash from Financing -0.12
Net change in Cash 0.52
Free Cash Flow 0.12
Particulars MAR 2022 (Values in Cr)
Net Income 0.74
Cash from Operations -0.34
Cash from Investing -0.86
Cash from Financing 1.53
Net change in Cash 0.22
Free Cash Flow 1.77
Particulars MAR 2021 (Values in Cr)
Net Income -2.52
Cash from Operations -0.01
Cash from Investing -0.42
Cash from Financing 1.83
Net change in Cash 1.24
Free Cash Flow 0.48
Particulars MAR 2020 (Values in Cr)
Net Income 0.43
Cash from Operations -1.48
Cash from Investing -0.27
Cash from Financing 1.71
Net change in Cash -0.14
Free Cash Flow -1.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 51.42 29.55 2.80 394.05 39.20 / 77.70
BLISS GVS PHARMA LTD 163.70 20.49 1.70 1724.85 92.25 / 184.95
CIPLA LTD 1448.00 25.33 4.12 116942.51 1268.40 / 1702.00
FERMENTA BIOTECH LIMITED 391.80 136.04 3.97 1153.11 145.00 / 440.00
GLAXOSMITHKLINE PHARMA LT 2077.20 43.89 21.03 35189.02 1825.05 / 3087.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 51.42 44.71 8.74 394.05 39.20 / 77.70
AMRUTAJAN HEALTH LTD 703.90 42.82 6.83 2035.02 571.00 / 861.40
ASTRAZENECA PHARMA IND LT 7030.35 136.54 25.87 17575.88 4050.15 / 8139.85
BLISS GVS PHARMA LTD 163.70 21.34 1.68 1724.85 92.25 / 184.95

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 74.20
  • 26 Days 79.60
  • 10 Days 77.30
  • 50 Days 81.70
  • 12 Days 77.40
  • 100 Days 75.20
  • 20 Days 79.60
  • 200 Days 49.40
71.33
PIVOT
First Resistance 72.65
Second Resistance 74.32
Third Resistance 75.64
First Support 69.66
Second Support 68.34
Third Support 66.67
RSI 32.43
MACD -2.26
Commodity Channel Index (CCI) -192.10
ADX 15.62
Williams % R -94.68

Over 1 Month

down

-15.00

Over 3 Months

down

-14.96

Over 6 Months

down

46.40

Over 1 Year

down

114.14

Over 3 Years

down

62.47

Over 5 Years

down

50.31

GUJARAT TERCE LABORATORIES LTD Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

GUJARAT TERCE LABORATORIES LTD Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Public
62.97
Promoter Holdings
37.02
FII
0.0
DII
0.0
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Abundant Trade Link Private Limited Shareholding of Promoter and Promoter Group 1075900.0 14.5
Prajapati Manjulaben S Shareholding of Promoter and Promoter Group 927150.0 12.49
Natwarbhai Parsottam Prajapati Shareholding of Promoter and Promoter Group 635817.0 8.57
Dheeraj Kumar Lohia Public Shareholding 93127.0 1.26
Sagar Saxena Public Shareholding 90001.0 1.21
Rishabh Negi Public Shareholding 75000.0 1.01
Aalap Natubhai Prajapati Shareholding of Promoter and Promoter Group 53677.0 0.72
Amritbhai P. Prajapati Shareholding of Promoter and Promoter Group 31510.0 0.42
Shobhanaben Natvarbhai Prajapati Shareholding of Promoter and Promoter Group 16173.0 0.22
Shachi Ravi Oza Shareholding of Promoter and Promoter Group 7500.0 0.1

GUJARAT TERCE LABORATORIES LTD

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About GUJARAT TERCE LABORATORIES LTD

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by GUJARAT TERCE LABORATORIES LTD

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Gujarat Terce Laboratories Ltd?

Answer Field

The share price of Gujarat Terce Laboratories Ltd for NSE is ₹ 0.00 and for BSE is ₹ 70.49.

What is the Market Cap of Gujarat Terce Laboratories Ltd?

Answer Field

The market cap of Gujarat Terce Laboratories Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 52.30 Cr. as of now.

What is the 52 Week High and Low of Gujarat Terce Laboratories Ltd?

Answer Field

The 52 Week High and Low of Gujarat Terce Laboratories Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 94.90 and ₹ 27.02.

How to Buy Gujarat Terce Laboratories Ltd share?

Answer Field

You can trade in Gujarat Terce Laboratories Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Gujarat Terce Laboratories Ltd?

Answer Field

The 1 year returns on the stock has been 114.14%.

What is the Current Share Price of Gujarat Terce Laboratories Ltd?

Answer Field

Gujarat Terce Laboratories Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 70.49 as on Jan 15 2025 03:10 PM.

What is the Market Cap of Gujarat Terce Laboratories Ltd Share?

Answer Field

The market cap of Gujarat Terce Laboratories Ltd for NSE ₹ 0.0 & for BSE ₹ 52.30 as on Jan 15 2025 03:10 PM.

What is the P/E Ratio of Gujarat Terce Laboratories Ltd Share?

Answer Field

As on Jan 15 2025 03:10 PM the price-to-earnings (PE) ratio for Gujarat Terce Laboratories Ltd share is 19.97.

What is the PB ratio of Gujarat Terce Laboratories Ltd Share?

Answer Field

As on Jan 15 2025 03:10 PM, the price-to-book (PB) ratio for Gujarat Terce Laboratories Ltd share is 11.94.

How to Buy Gujarat Terce Laboratories Ltd Share?

Answer Field

You can trade in Gujarat Terce Laboratories Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Gujarat Terce Laboratories Ltd Share on Bajaj Broking App?

Answer Field

To buy Gujarat Terce Laboratories Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Gujarat Terce Laboratories Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs+ Users

icon-with-text

4.4+ App Rating

icon-with-text

4 Languages

icon-with-text

₹5300+ Cr MTF Book

icon-with-text
loader